Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Protein phosphatase 3 regulatory subunit B alpha (PPP3R1) is the regulatory subunit of the enzyme calcineurin, a calcium-dependent and calmodulin-stimulated protein phosphatase. PPP3R1 confers calcium sensitivity to the catalytic subunit, forming a functional phosphatase complex involved in various signaling pathways, including the calcineurin-NFAT signaling cascade important for immune, cardiac, and neural processes. Mutations or variants in PPP3R1 are implicated in diseases such as Alzheimer's disease and dilated cardiomyopathy[1][2][3][5].
Inhibition of calcineurin activity (via immunosuppressant drugs such as cyclosporin A and tacrolimus, which target the calcineurin complex containing PPP3R1)
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Protein phosphatase 3 regulatory subunit B alpha (PPP3R1).